SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061551
Filing Date
2023-11-09
Accepted
2023-11-09 08:00:48
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20230930.htm   iXBRL 10-Q 2145134
2 EX-31.1 pmvp-ex31_1.htm EX-31.1 18953
3 EX-31.2 pmvp-ex31_2.htm EX-31.2 18921
4 EX-32.1 pmvp-ex32_1.htm EX-32.1 10254
5 EX-32.2 pmvp-ex32_2.htm EX-32.2 10742
  Complete submission text file 0000950170-23-061551.txt   7758467

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pmvp-20230930_cal.xml EX-101.CAL 41006
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20230930.xsd EX-101.SCH 43221
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20230930_lab.xml EX-101.LAB 377751
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pmvp-20230930_def.xml EX-101.DEF 119047
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20230930_pre.xml EX-101.PRE 271784
57 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20230930_htm.xml XML 1535695
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 231390140
SIC: 2834 Pharmaceutical Preparations